Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SEM | Common Stock | Sale | -$1.52M | -50K | -0.72% | $30.36 | 6.89M | Jul 10, 2023 | Direct | F1, F2 |
holding | SEM | Common Stock | 1.28M | Jul 10, 2023 | By the Robert A. Ortenzio Descendants Trust | F3 | |||||
holding | SEM | Common Stock | 3.8M | Jul 10, 2023 | By the Rocco A. Ortenzio Separate Exempt Descendants Trust | F3 | |||||
holding | SEM | Common Stock | 280K | Jul 10, 2023 | By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio | F3 | |||||
holding | SEM | Common Stock | 280K | Jul 10, 2023 | By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio | F3 | |||||
holding | SEM | Common Stock | 280K | Jul 10, 2023 | By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio | F3 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.48 to $30.585, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote |
F3 | The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |